SLC2A1 and non-small cell lung carcinoma: Furthermore, the effect of RP11-544M22.13 on chemotherapy resistance and malignant potential of NSCLC cells was mediated by miR-1291/SLC2A1 signaling, which provided a new target for NSCLC therapy.